
Reset all filters
01 2Gowling WLG (Canada) LLP
Reset all filters
01 12820681
02 12878928
Reset all filters
01 2TISAGENLECLEUCEL
Reset all filters
01 2SUSPENSION
Reset all filters
01 12031-12-09
02 12033-07-12
Patent Expiration Date : 2031-12-09
Date Granted : 2018-10-23
Brand Name : KYMRIAH
Patent Number : 2820681
Filing Date : 2011-12-09
Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells
Dosage Form : SUSPENSION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2031-12-09
Date Granted : 2018-10-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-07-12
Date Granted : 2023-03-14
Brand Name : KYMRIAH
Patent Number : 2878928
Filing Date : 2013-07-12
Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells
Dosage Form : SUSPENSION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2033-07-12
Date Granted : 2023-03-14
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF